IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NLS Pharmaceutics LTD

CUSIP: H57830111 | 16 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2025

Clear Street Group Inc.57,762
0.0% of portfolio›$1.0K
Susquehanna International Group, LLP45,830
0.0% of portfolio›$731
UBS Group AG424
0.0% of portfolio›$8
StyleTurnoverLocationFiled
Clear Street Group Inc.
57,762$1.0K0.0%Agg GrowthMediumNew York, NY2025-11-14
Susquehanna International Group, LLP
45,830$7310.0%GrowthHighBala Cynwyd, PA2025-11-14
UBS Group AG
424$80.0%CoreMediumZurich, Switzerland2025-11-13